VRTX Articles, Vertex Pharmaceuticals Incorporated - From 10/17/23

Cantor Fitzgerald has downgraded CRISPR Therapeutics AG (NASDAQ: CRSP) to Neutral from Overweight, noting that its sickle cell ...

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 10 years by 7.47% on an annualized basis producing an average annual...

CNBC's Jim Cramer has drawn investors' attention to Vertex Pharmaceuticals (NASDAQ: VRTX), a biotechnology company curr...

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Topgolf Callaway Brands Corp. (NYSE: MODG) is making money. "I think ...

The Nasdaq 100 closed lower by over 50 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares,...

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 15 years by 8.49% on an annualized basis producing an average annual...

In the current market session, Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) stock price is at $353.85, after a 0.12% decrease. However, over the past ...

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 10 years by 6.6% on an annualized basis producing an average annual ...